Newomics Closes $3.9M Series A Round

Mass spec technology firm Newomics has closed a $3.9 million Series A funding round.

The Berkeley, California-based company closed the round on Wednesday, said Daojing Wang, Newomics' founder and CEO, adding that it surpassed its initial target of $3.5 million. The round was led by the Berkeley Catalyst Fund and the Photon Fund.

According to Wang, the funds will be used to expand the company's management team and complete commercialization of its silicon-based multinozzle emitter array (MEA) technology, which the company said increases the sensitivity and robustness of LC-MS, as well as develop assays based on that technology.

Read the full story at GenomeWeb